Showing results (2611-2620 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 25, 2012
Inhibition of V-ATPase and carbonic anhydrases as interference strategy with tumor acidification processesMario Perez-Sayans, Abel Garcia-Garcia, Andrea Scozzafava, et al.Current Pharmaceutical Design|February 28, 2012
Systemic sclerosis-related pulmonary hypertension: unique characteristics and future treatment targetsTheodoros Dimitroulas, Georgios Giannakoulas, Haralambos Karvounis, et al.Current Pharmaceutical Design|February 28, 2012
Excess cardiovascular risk in inflammatory rheumatic diseases: pathophysiology and targeted therapyAltan Onat, Haner DireskeneliCurrent Pharmaceutical Design|February 28, 2012
The effect of anti-B-cell therapy on the development of atherosclerosis in patients with rheumatoid arthritisDiana S Novikova, Tatyana V Popkova, Eugeny L NasonovCurrent Pharmaceutical Design|February 28, 2012
Marine n-3 fatty acids for cardiovascular risk reduction and disease control in rheumatoid arthritis: "kill two birds with one stone"?Victoria G Rontoyanni, Petros P Sfikakis, George D Kitas, et al.Current Pharmaceutical Design|March 1, 2012
Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine systemFederica Marchesi, Fabio Grizzi, Luigi Laghi, et al.Current Pharmaceutical Design|March 2, 2012
Luminescent G-quadruplex probesDik-Lung Ma, Daniel Shiu-Hin Chan, Hui Yang, et al.Current Pharmaceutical Design|March 2, 2012
RNA G-quadruplexes: G-quadruplexes with "U" turnsTani Agarwal, Gopal Jayaraj, Satya Prakash Pandey, et al.Current Pharmaceutical Design|March 2, 2012
Targeting DNA G-quadruplex structures with peptide nucleic acidsIgor G Panyutin, Mykola I Onyshchenko, Ethan A Englund, et al.Current Pharmaceutical Design|March 2, 2012
Searching drug-like anti-cancer compound(s) based on G-quadruplex ligandsQian Li, Jun-Feng Xiang, Hong Zhang, et al.Pageof 1,008